Table 4. Promising therapeutic agents for HCL [114, 116, 118, 120, 125].
Agent | Mechanism of action |
---|---|
Vemurafenib, dabrafenib | Inhibition of BRAF |
Ibrutinib | Bruton’s tyrosine kinase inhibitor |
Trematinib, selumetinib | MAPK (mitogen activated protein kinase) inhibitors |
Moxetumomab pasudotox | High-affinity anti-CD22 immunotoxin |